mounjaro glp-1 market impact Receptor Agonist Growth Analysis GLP-1 drugs Mounjaro and Zepbound
Description
Injection site reactions, fatigue during initial titration, and appetite suppression patterns are broadly comparable
This issue peaked at week 24 and then declined at weeks 36 and 48
Rheumatoid arthritis and body weight are not two separate problems
Despite their benefits, GLP-1 medications present unique challenges at a national level
Schneck, Karen, and Shweta Urva
Although past studies have demonstrated that Zepbound performed better than Wegovy, Lillys trial is the first to compare them side-by-side rather than relying on previously published data
